Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Stenvang

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Basic & Clinical Pharmacology & Toxicology|July 7, 2020
Four phase 1 trials to evaluate the safety and pharmacokinetic profile of single and repeated dosing of SCO-101 in adult male and female volunteersTroels K Bergmann, Tore B Stage, Jan Stenvang, et al.
Biomolecules|October 23, 2021
Reversal of ABCG2/BCRP-Mediated Multidrug Resistance by 5,3',5'-Trihydroxy-3,6,7,4'-Tetramethoxyflavone Isolated from the Australian Desert Plant <i>Eremophila galeata</i> ChinnockMalene J Petersen, Xamuel L Lund, Susan J Semple, et al.
International Journal of Molecular Sciences|December 8, 2019
Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal CancerStine F Thorsen, Irina Gromova, Ib J Christensen, et al.
Frontiers in Oncology|May 31, 2021
A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast CancerPeide Huang, Fengyu Li, Zongchao Mo, et al.
Nucleic Acids Research|July 15, 2009
Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSFJesper Worm, Jan Stenvang, Andreas Petri, et al.
BMC Cancer|May 19, 2015
The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cellsElena Pedraz-Cuesta, Sandra Christensen, Anders A Jensen, et al.
Cancers|April 3, 2021
Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic ResistanceThiago S Lima, Diego Iglesias-Gato, Luciano D O Souza, et al.
Journal of Cellular Physiology|January 14, 2017
State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemiaHamed Mirzaei, Sima Fathullahzadeh, Razieh Khanmohammadi, et al.
Protein Expression and Purification|July 8, 2014
Purification and characterization of bioactive his6-tagged recombinant human tissue inhibitor of metalloproteinases-1 (TIMP-1) protein expressed at high yields in mammalian cellsLena Vinther, Ulrik Lademann, Elisabeth Veyhe Andersen, et al.
BMC Cancer|February 13, 2016
A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplificationLine S Tarpgaard, Camilla Qvortrup, Sune B Nygård, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Basic & Clinical Pharmacology & Toxicology|July 7, 2020
Four phase 1 trials to evaluate the safety and pharmacokinetic profile of single and repeated dosing of SCO-101 in adult male and female volunteersTroels K Bergmann, Tore B Stage, Jan Stenvang, et al.
Biomolecules|October 23, 2021
Reversal of ABCG2/BCRP-Mediated Multidrug Resistance by 5,3',5'-Trihydroxy-3,6,7,4'-Tetramethoxyflavone Isolated from the Australian Desert Plant <i>Eremophila galeata</i> ChinnockMalene J Petersen, Xamuel L Lund, Susan J Semple, et al.
International Journal of Molecular Sciences|December 8, 2019
Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal CancerStine F Thorsen, Irina Gromova, Ib J Christensen, et al.
Frontiers in Oncology|May 31, 2021
A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast CancerPeide Huang, Fengyu Li, Zongchao Mo, et al.
Nucleic Acids Research|July 15, 2009
Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSFJesper Worm, Jan Stenvang, Andreas Petri, et al.
BMC Cancer|May 19, 2015
The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cellsElena Pedraz-Cuesta, Sandra Christensen, Anders A Jensen, et al.
Cancers|April 3, 2021
Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic ResistanceThiago S Lima, Diego Iglesias-Gato, Luciano D O Souza, et al.
Journal of Cellular Physiology|January 14, 2017
State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemiaHamed Mirzaei, Sima Fathullahzadeh, Razieh Khanmohammadi, et al.
Protein Expression and Purification|July 8, 2014
Purification and characterization of bioactive his6-tagged recombinant human tissue inhibitor of metalloproteinases-1 (TIMP-1) protein expressed at high yields in mammalian cellsLena Vinther, Ulrik Lademann, Elisabeth Veyhe Andersen, et al.
BMC Cancer|February 13, 2016
A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplificationLine S Tarpgaard, Camilla Qvortrup, Sune B Nygård, et al.
Pageof 8